Biocell Technology, LLC
Records under this name other than patents Biocell Technology, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Biocell Technology, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,799,348 | Therapeutic composition comprising hyaluronic acid and chondroitin sulfate and method of making same Term ended Term ended Nov 24, 2022 · From the USPTO record | Term ended | Term ended Nov 24, 2022 | From the USPTO record |
| US 8,563,045 | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same Term ended Term ended Nov 21, 2022 · From the USPTO record | Term ended | Term ended Nov 21, 2022 | From the USPTO record |
| US 6,780,841 | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same Term ended Term ended Jun 25, 2022 · From the USPTO record | Term ended | Term ended Jun 25, 2022 | From the USPTO record |
| US 7,091,180 | Hyaluronic acid and chondroitin sulfate based hydrolyzed collagen type II and method of making same Formerly held Term ended Term ended Dec 10, 2021 · From the USPTO record | Term ended | Term ended Dec 10, 2021 | From the USPTO record |
| US 6,323,319 | Method of making hydrolyzed collagen type II Term ended Term ended Dec 2, 2019 · From the USPTO record | Term ended | Term ended Dec 2, 2019 | From the USPTO record |
| US 6,025,327 | Hydrolyzed collagen type II and use thereof Formerly held Term ended Term ended Aug 8, 2017 · From the USPTO record | Term ended | Term ended Aug 8, 2017 | From the USPTO record |
| US 5,843,920 | Anionic saccharides for extraction of anti-angiogenic protein from cartilage Term ended Term ended no later than Dec 1, 2018 · Low confidence | Term ended | Term ended no later than Dec 1, 2018 | Low confidence |